For example, ERβ is known to negatively regulate peroxisome proliferating receptor gamma (PPARγ) by competing for a shared coactivator (Foryst-Ludwig et al., 2008) resulting in suppression of adipocyte proliferation (i.e., an anti-obesity effect). Here, ESR2 is linked to obesity disorder.